Select Cognition Coverage and Published Editorials
Topline Results Are In: Cognition Therapeutics’ Drug To Fight Dementia With Lewy Bodies Shows Encouraging Results In Phase 2 Trial
Benzinga
By Meg Flippin
December 19, 2024
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld Today
By Randy Osborne
December 18, 2024
Cognition’s phase 2 SHIMMER results finally allow dementia drug to shine
Fierce Biotech
By James Waldron
December 18, 2024
Exploring Innovative Approaches in Alzheimer’s and Dementia Treatment
Clinical Trial Vanguard
By Moe Alsumidaie
November 26, 2024
An understudied dementia soon to get a pair of Phase II readouts
BioCentury
By Selena Koch
November 19, 2024
Alzheimer’s Drug Shows Slower Cognitive Decline in Lower Tau Patients
Genetic Engineering & Biotechnology News
By Alex Philippidis
November 5, 2024